WallStreetZenWallStreetZen

NASDAQ: CLGN
Collplant Biotechnologies Ltd Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Collplant Biotechnologies earnings were -$13.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CLGN earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$1.5M, down 62.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CLGN reported annual earnings of -$16.6M, with 136.6% growth.

CLGN earnings history

Current Revenue
$2.5M
Current Earnings
-$13.9M
Current Profit Margin
-560.9%

CLGN Return on Equity

Current Company
-87.3%
Current Industry
-60.2%
Current Market
31.5%
CLGN's Return on Equity (-87.3%)... subscribe to Premium to read more.
High Return on Equity Performance

CLGN undefined

Current Company
-65.3%
Current Industry
-2.5%
CLGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CLGN announces earnings.

CLGN undefined

Current Company
-99.08%
Current Industry
5.8%
CLGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CLGN vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CLGN-$13.37M-$13.87MN/A-$1.22
XFOR$26.84M$14.60MN/A$2.14
NRXS-$8.19M-$8.82MN/A-$1.21
SABS-$30.38M-$34.28MN/A-$3.70
LPCN-$5.32M-$5.37MN/A-$1.00
View Top Biotech Stocks

Collplant Biotechnologies Earnings Reports & History FAQ

What were Collplant Biotechnologies's earnings last quarter?

On CLGN's earnings call on Invalid Date, Collplant Biotechnologies (NASDAQ: CLGN) reported Q1 2025 earnings per share (EPS) of -$0.13, up 64.86% year over year. Total CLGN earnings for the quarter were -$1.45 million. In the same quarter last year, Collplant Biotechnologies's earnings per share (EPS) was -$0.37.

If you're new to stock investing, here's how to buy Collplant Biotechnologies stock.

Is Collplant Biotechnologies profitable or losing money?

As of the last Collplant Biotechnologies earnings report, Collplant Biotechnologies is currently losing money. Collplant Biotechnologies's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$13.87 million, a 84.9% increase year over year.

What was CLGN's earnings growth in the past year?

As of Collplant Biotechnologies's earnings date in Invalid Date, Collplant Biotechnologies's earnings has grown year over year. CLGN earnings in the past year totalled -$13.87 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.